Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
LOADING
|||
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 29.46% |
| Q2 2025 | 9.22% |
| Q1 2025 | -23.46% |
| Q4 2024 | 13.19% |
| Q3 2024 | -33.94% |
| Q2 2024 | -1.11% |
| Q1 2024 | -55.54% |
| Q4 2023 | 26.14% |
| Q3 2023 | -45.07% |
| Q2 2023 | 27.55% |
| Q1 2023 | -26.93% |
| Q4 2022 | 13.07% |
| Q3 2022 | -14.18% |
| Q2 2022 | -22.30% |
| Q1 2022 | 0.00% |